D-Keine Introduction AVITA Medical, Inc. (NASDAQ:RCEL) stock is down 47% since my last look in March. The title said it all: “Unconvincing Growth Amid Fierce Competition In The Burn Care Sector.” My recommendation was hold, citing “unresolved concerns over S&M spending efficiency and competitive advantage.” The company subsequently has released two earnings reports and launched RECELL GO, so let's take another look. AVITA Medical: Struggling to Balance Growth and Profitability RECELL GO was FDA-approved ...